C-TIL052A
/ AbelZeta Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 27, 2022
Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer
(clinicaltrials.gov)
- P1 | N=20 | Recruiting | Sponsor: Fudan University
New P1 trial • Cervical Cancer • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1